Furthermore, SIRT-1 activity has anti-oxidant and anti-inflammatory effects on liver and kidney tissues, which play crucial roles in NAFLD and CKD [87,88]. The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatotic liver disease.